BioFactura
Frederick, US · Delaware corporation
Find your way into BioFactura
Sign up to see every warm intro you have to BioFactura
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioFactura team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioFactura is a clinical-stage biopharmaceutical company developing biologics and biosimilars, and has launched Capitol Biologics, a CDMO division offering contract development and manufacturing services to advance biologics from concept to clinic.
Founders & leadership
DS

Darryl SampeyFounderDarryl Sampey is a biopharmaceutical executive with over 30 years of experience in biologics and biosimilar development. As Co-Founder and CEO of BioFactura, a clinical-stage biopharmaceutical company with a CDMO division, he has raised substantial funding, built cGMP manufacturing capabilities, and led programs from discovery through clinical development and commercialization.
Board
JN
Jeffrey N Hausfeld, MDBoard director
Funding
SEC filings, press & company announcements$1.8M disclosed across 1 of 2 rounds · 2015–2018
- Undisclosed amountSeries BMay 2018Source ↗
▶$1.8MraisedMay 2016 · 22 investors · BiotechnologyRule 506(b)
▶$1.8MraisedMay 2016 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey N Hausfeld, MDExecutive Officer, Director
- Darryl SampeyExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- Minimum investment
- $25K
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
CatalentCatalent is a global Contract Development and Manufacturing Organization (CDMO) that helps pharma, biotech, and self-care companies develop, manufacture, and deliver drug products and consumer health solutions. Its services span oral dose, biologics, specialty, and clinical supply, from early-stage design through commercial manufacturing.
InvenInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.
Companies working in the same space as BioFactura.
Frequently asked questions
- What does BioFactura do?
- BioFactura is a clinical-stage biopharmaceutical company developing biologics and biosimilars, and has launched Capitol Biologics, a CDMO division offering contract development and manufacturing services to advance biologics from concept to clinic.
- Who founded BioFactura?
- BioFactura was founded by Darryl Sampey.
- How much funding has BioFactura raised?
- BioFactura has disclosed $1.8M raised across 1 of its 2 known rounds.
- Where is BioFactura headquartered?
- BioFactura is headquartered in Frederick, US.

